Monopar Therapeutics
MNPR
#8223
Rank
NZ$0.32 B
Marketcap
$53.60
Share price
-13.27%
Change (1 day)
912.84%
Change (1 year)

EPS for Monopar Therapeutics (MNPR)

EPS in 2023 (TTM): -$1.26

According to Monopar Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.38. In 2022 the company made an earnings per share (EPS) of -$1.48 a decrease over its 2021 EPS that were of -$1.32.

EPS history for Monopar Therapeutics from 2017 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.26-15.04%
2022-$1.4812.16%
2021-$1.3227.59%
2020-$1.0443.71%
2019-$0.7233.52%
2018-$0.54-80.97%
2017-$2.84

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.90 183.12%๐Ÿ‡บ๐Ÿ‡ธ USA